Addyi was initially authorised from the FDA in August 2015 to treat hypoactive sexual need dysfunction (HSDD) in premenopausal women. That's just another way of saying it boosts intercourse push (also known as libido) in Women of all ages who have not reached menopause. It was the very first this sort of drug accredited for this use.Meant to help s